83 filings
8-K
CALA
Calithera Biosciences, Inc.
25 Jan 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6:09am
8-K
CALA
Calithera Biosciences, Inc.
9 Jan 23
Calithera Biosciences Announces Board Approval of Complete Liquidation and Dissolution
8:05am
8-K
CALA
Calithera Biosciences, Inc.
14 Nov 22
Calithera Biosciences Reports Third Quarter 2022 Financial Results and Business Update
4:09pm
8-K
CALA
Calithera Biosciences, Inc.
29 Sep 22
Termination of a Material Definitive Agreement
4:02pm
8-K
CALA
Calithera Biosciences, Inc.
15 Aug 22
Calithera Biosciences Reports Second Quarter 2022 Financial Results and Recent Highlights
5:00pm
8-K
fa66yny2pw c4
14 Jun 22
Amendments to Articles of Incorporation or Bylaws
4:31pm
8-K
87ayg 7wno
3 Jun 22
Submission of Matters to a Vote of Security Holders
4:33pm
8-K
e82qm ai0m3
23 May 22
Entry into a Material Definitive Agreement
4:39pm
8-K
tm1j3mw
10 May 22
Calithera Biosciences Reports First Quarter 2022 Financial Results and Recent Highlights
4:06pm
8-K
akizk3x
12 Apr 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:21pm
8-K
ru6 pf1oiobb4f7
31 Mar 22
Other Events
4:08pm
8-K
0par0rm6
31 Mar 22
Calithera Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Highlights
12:00am
8-K
hoe kkycd6pipsbt
28 Jan 22
Departure of Directors or Certain Officers
4:06pm
8-K
3meyv 2gtofqp6lf75
5 Jan 22
Other Events
4:06pm
8-K
2wjfukvjl4kw681
30 Dec 21
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:06pm
8-K
kd1sr6fa6csak
9 Nov 21
Calithera Biosciences Reports Third Quarter 2021 Financial Results and Recent Highlights
4:31pm
8-K
ktiti8k2y
5 Nov 21
Calithera Biosciences Announces Decision to Discontinue KEAPSAKE Clinical Trial
6:10am
8-K
hibbrts312o4
19 Oct 21
Calithera Expands Oncology Pipeline with Acquisition of Two Clinical-Stage Assets from Takeda Pharmaceuticals
6:08am
8-K
918lao25864rz56m
16 Sep 21
Other Events
4:01pm
8-K
kzvmc
5 Aug 21
Calithera Biosciences Reports Second Quarter 2021 Financial Results and Recent Highlights
4:35pm